{"latest_checked": "2026-07-31T22:10:54.858067+00:00", "coverage_count": 5078, "recent_count": 3, "transaction_limit": 160, "filters": {"q": "", "ticker": "LYEL", "sector": "", "industry": "", "side": "", "start": "2026-06-18", "end": "2026-08-02"}, "summary": {"total": 3, "acquisition_count": 0, "disposal_count": 3, "acquisition_value": 0.0, "acquisition_value_label": "$0", "disposal_value": 274.3, "disposal_value_label": "$274", "net_value": -274.3, "net_value_label": "$-274", "flow_tone": "negative", "largest_value_label": "$137", "top_sector": "Healthcare", "window_label": "18 Jun 2026 to 02 Aug 2026"}, "charts": {"sectors": [{"ticker__sector": "Healthcare", "count": 3, "value": "274.3000", "bar_width": 100.0, "sector_slug": "healthcare", "value_label": "$274"}], "days": [{"transaction_date": "2026-06-29", "acquisitions": 0, "disposals": 1, "total": 1, "bar_width": 100.0}, {"transaction_date": "2026-07-16", "acquisitions": 0, "disposals": 1, "total": 1, "bar_width": 100.0}, {"transaction_date": "2026-07-17", "acquisitions": 0, "disposals": 1, "total": 1, "bar_width": 100.0}], "side_mix": {"acquisitions": 0, "disposals": 3, "acquisition_share": 0.0, "disposal_share": 100.0}}, "company_flows": [{"symbol": "LYEL", "name": "Lyell Immunopharma Inc", "sector": "Healthcare", "industry": "Biotechnology", "sector_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/", "industry_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/industries/biotechnology/", "latest_transaction": "2026-07-17", "acquisitions": 0, "disposals": 3, "acquired_value": 0.0, "acquired_value_label": "$0", "disposed_value": 274.3, "disposed_value_label": "$274", "net_value": -274.3, "net_value_label": "$-274", "acquisition_share": 0.0, "disposal_share": 100.0, "detail_url": "https://sharemaestro.com/insider-activity/company/lyel/", "research_links": {"chart": "/terminal/918e8a8f-6a79-44de-97d5-69c0a0d00ca0/", "report": "/terminal/918e8a8f-6a79-44de-97d5-69c0a0d00ca0/report/", "factor": "/factors/ticker/918e8a8f-6a79-44de-97d5-69c0a0d00ca0/"}}], "company_overview": [{"symbol": "LYEL", "name": "Lyell Immunopharma Inc", "sector": "Healthcare", "industry": "Biotechnology", "exchange": "NASDAQ", "country": "US", "sector_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/", "industry_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/industries/biotechnology/", "latest_transaction": "2026-07-17", "filings": 3, "acquisitions": 0, "disposals": 3, "acquired_value": 0.0, "acquired_value_label": "$0", "disposed_value": 274.3, "disposed_value_label": "$274", "net_value": -274.3, "net_value_label": "$-274", "acquisition_share": 0.0, "disposal_share": 100.0, "tone": "Disposal-led", "tone_class": "negative", "detail_url": "https://sharemaestro.com/insider-activity/company/lyel/", "research_links": {"chart": "/terminal/918e8a8f-6a79-44de-97d5-69c0a0d00ca0/", "report": "/terminal/918e8a8f-6a79-44de-97d5-69c0a0d00ca0/report/", "factor": "/factors/ticker/918e8a8f-6a79-44de-97d5-69c0a0d00ca0/"}}], "transactions": [{"symbol": "LYEL", "name": "Lyell Immunopharma Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-17", "executive": "INNOVATIVE, CELLULAR THERAPEUTICS HOLDINGS LTD", "executive_title": "10% Owner", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 10.0, "share_price": 13.7, "transaction_value": 137.0, "fetched_at": "2026-07-31T11:11:09.288700+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/lyel/", "research_links": {"chart": "/terminal/918e8a8f-6a79-44de-97d5-69c0a0d00ca0/", "report": "/terminal/918e8a8f-6a79-44de-97d5-69c0a0d00ca0/report/", "factor": "/factors/ticker/918e8a8f-6a79-44de-97d5-69c0a0d00ca0/"}}, {"symbol": "LYEL", "name": "Lyell Immunopharma Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-16", "executive": "INNOVATIVE, CELLULAR THERAPEUTICS HOLDINGS LTD", "executive_title": "10% Owner", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 10.0, "share_price": 13.73, "transaction_value": 137.3, "fetched_at": "2026-07-31T11:11:09.292013+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/lyel/", "research_links": {"chart": "/terminal/918e8a8f-6a79-44de-97d5-69c0a0d00ca0/", "report": "/terminal/918e8a8f-6a79-44de-97d5-69c0a0d00ca0/report/", "factor": "/factors/ticker/918e8a8f-6a79-44de-97d5-69c0a0d00ca0/"}}, {"symbol": "LYEL", "name": "Lyell Immunopharma Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-29", "executive": "INNOVATIVE, CELLULAR THERAPEUTICS HOLDINGS LTD", "executive_title": "10% Owner", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 76000.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-17T11:02:14.755600+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/lyel/", "research_links": {"chart": "/terminal/918e8a8f-6a79-44de-97d5-69c0a0d00ca0/", "report": "/terminal/918e8a8f-6a79-44de-97d5-69c0a0d00ca0/report/", "factor": "/factors/ticker/918e8a8f-6a79-44de-97d5-69c0a0d00ca0/"}}], "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}